Lexaria Bioscience Corp. (LEXX)
Pharmaceutical Preparations
Latest Price
$3.21
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
--
P/B Ratio
--
Institutional Ownership
6.5% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Invenomic Capital Management LP | 345.7K | -- | 1.39% | -96.6K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 298.4K | -- | 1.20% | +76.1K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 250.4K | -- | 1.01% | -43.7K | 2026-06-30 |
| CITADEL ADVISORS LLC | 156.9K | -- | 0.63% | +143.4K | 2026-06-30 |
| TORONTO DOMINION BANK | 100.0K | -- | 0.40% | -40.0K | 2026-06-30 |
| VANGUARD FIDUCIARY TRUST CO | 94.2K | -- | 0.38% | -- | 2026-06-30 |
| HRT FINANCIAL LP | 65.0K | -- | 0.26% | +46.6K | 2026-06-30 |
| UBS Group AG | 47.0K | -- | 0.19% | -5.7K | 2026-06-30 |
| NORTHERN TRUST CORP | 39.8K | -- | 0.16% | +21.4K | 2026-06-30 |
| STATE STREET CORP | 39.3K | -- | 0.16% | -- | 2026-06-30 |